Alternatives to EnteroBiotix
EnteroBiotix is a Biotechnology tool: developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health. Here are the 53 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to EnteroBiotix
Jazz Pharmaceuticals3.0 out of 5 (1)Global biopharmaceutical company focused on oncology and neuroscience treatments.
C4 TherapeuticsNot ratedBiopharmaceutical company developing novel cancer therapies using targeted protein degradation.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
FreenomeNot ratedFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
QuartzyNot ratedA vertically-integrated procurement platform for the life sciences industry.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
ImmunoScapeNot ratedDeveloping novel immunotherapies and diagnostics for cancer.
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Rocket PharmaceuticalsNot ratedA biotechnology company developing genetic therapies for rare disorders.
Adaptyv BiosystemsNot ratedAutomated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
Showing the next 20 closest matches. See the rest on the EnteroBiotix profile.
Sponsored rows are paid and labelled. Advertise on this page
